LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients
Phase of Trial: Phase IV
Latest Information Update: 04 Dec 2016
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms LIVE-C-Free
- 28 Mar 2016 Protocol amended as phase changed from 3 to 4, treatment arms changed from 2 to 4 as reported by ClinicalTrials.gov.
- 28 Mar 2016 Planned End Date changed from 1 Feb 2018 to 1 Jun 2018 as reported by ClinicalTrials.gov.
- 28 Mar 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Jun 2017 as reported by Clinicaltrials.gov.